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ABSTRACT
To evaluate the clinical outcome after arthroscopic matrix-associated injectable autologous chondrocyte im-
plantation (ACI) in patients with large full-thickness acetabular cartilage defects. ACI was performed in young
patients with full-thickness acetabular cartilage defects 2 cm2 in a two-step arthroscopic procedure. The patients
were followed closely with clinical examinations and pre- and postoperative scores. The modiﬁed Harris Hip
Score (mHHS), iHOT33 questionnaire (iHOT33) and the Subjective Hip Value (SHV) were surveyed.
Demographic patient data was evaluated for inﬂuencing factors for the pre- and postoperative results. Thirty-two
consecutive cases (4 female, 28 male, mean age 33 years) were included. The average defect size was 4.9 (range:
2–6) cm2. They were followed at 6, 12, 24 and 36 months postoperatively. Patients had improved signiﬁcantly
from 64 to 91 points (P< 0.001) in the mHHS, from 44% to 86% (P< 0.001) in the iHOT33 and from 54% to
87% (P< 0.001) in the SHV. No surgery related complications were noted. Cell cultivation failed in two cases
(7%) and the patients decided for a repeated harvesting of cartilage cylinders followed by a successful ACI.
Patients age and size of the cartilage defect showed no signiﬁcant correlation with the pre- or postoperative
results. Injectable ACI is a reliable procedure treating full-thickness acetabular cartilage defects leading to promis-
ing results 3 years postoperatively with a signiﬁcant increase in all scores despite large acetabular cartilage defects
in the weight-bearing zone.
INTRODUCTION
Acetabular cartilage defects due to femoroacetabular im-
pingement (FAI) represent a challenging condition in a
mostly young patient population [1]. Cartilage defects re-
semble a severe pathology due to its limited healing poten-
tial and have shown to be the major prognostic factor in
FAI surgery [2, 3]. Therefore, optimal therapy of acetabu-
lar cartilage defects is of great interest.
Autologous cartilage implantation (ACI) is an established
therapy option for cartilage defects in the knee showing
significant better functional scores and tissue regeneration
in large defects compared with the microfracture procedure
[4–7]. In hip surgery, microfracture has been the treatment
of choice for acetabular cartilage defects regardless of its
size so far [3, 8–11]. Microfracture leads to a good filling
of the cartilage defect but showed mostly fibrocartilaginous
tissue regeneration in histopathologic evaluations [12].
With the good long-term results of ACI in knee surgery
the technique has been transferred to the hip for the treat-
ment of acetabular cartilage defects. First investigations
showed excellent results of the ACI procedure using scaf-
fold material in the hip [13, 14], but the use of a scaffold is
technically demanding in the concave acetabulum and has
the risk of a scaffold dislocation [15]. Therefore, scaffold
free matrix-associated injectable agents have been devel-
oped with the potential of an easier and less invasive
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implantation process. Those agents have no need of a scaf-
fold material as they are applied as highly adhesive spheres
or gel. First studies could proof the feasibility of this pro-
cedure even in the ‘overhanging’ situation of the typical an-
terolateral acetabular defects in patients in supine position
[16, 17]. Early results are promising but only showed a
limited follow-up time of 12 months [18].
PURPOSE
To evaluate the clinical outcome after arthroscopic matrix-
associated injectable autologous chondrocyte implantation
(ACI) in patients with large full-thickness acetabular cartil-
age defects.
Our hypothesis was that modern cellular cartilage pro-
cedures allow favorable results despite large acetabular car-
tilage defects.
MATERIALS AND METHODS
Patients with symptomatic FAI after failed conservative
therapy were offered an ACI procedure in case of a sus-
pected cartilage defect in the routinely performed pre-
operative MRI. In case of an intraoperative confirmation of
a full-thickness cartilage defect 2 cm2 and the patient re-
quest an ACI procedure was initiated by harvesting osteo-
chondral cylinders from the head neck junction for cell
cultivation. In a second arthroscopic surgery, the cultivated
chondrocytes were implanted directly into the debrided
defect area.
The study was approved by the local institutional review
board (EA2/154/14).
Inclusion criteria
Patients under the age of 50 years with an isolated acetabu-
lar full-thickness cartilage defect 2 cm2 in a contained de-
fect situation and a minimum of follow-up of 36 months.
Exclusion criteria
Patients older than 50 years, patients with a Kellgren and
Lawrence Score [19] >1, combined acetabular and fem-
oral cartilage defects, radiological signs for dysplasia
(Center Edge Angle <25, Tonnis Angle >10) and
patients unwilling to undergo a two-step ACI procedure.
Surgical technique
The patient was placed in supine position on a radiolucent
carbon extension device (MAQUET, Rastatt, Germany).
Special care was taken that the perineal post and feet were
well padded. Hip arthroscopy was performed starting peri-
pheral first and the underlying cam deformity was cor-
rected thoroughly using a burr. After safely establishing
portals to the central compartment [20], the labral and
cartilage damage was investigated. In case of an acetabular
cartilage defect 2 cm2 the defect area was debrided using
a curette to create a stable margin (Fig. 1). The size of the
cartilage defect was measured using an arthroscopic probe
with a defined 5mm marking at the tip. The width and
length of the defect area were then multiplied for the calcu-
lation of the defect size. Labral tears were repaired in either
labral base or loop technique depending on the quality of
the labrum [21, 22]. If a segmental labral defect was pre-
sent, a labral reconstruction was performed. Finally, cartil-
age–bone cylinders were harvested from the head–neck
junction using an arthroscopic cartilage punch (Karl Storz,
Tuttlingen, Germany). The cylinders along with patient’s
serum were sent to the laboratory (co.don AG, Teltow,
Germany) for further cell cultivation.
After cell cultivation, the chondrocyte spheroids were
implanted in a second arthroscopic surgery usually 6–8
weeks later. Intraoperatively the stability of the labrum as
well as the integrity and the margins of the healthy cartil-
age were reinsured to reconfirm a contained defect situ-
ation. The defect area was debrided again using a curette.
After removing all fluid out of the joint, the chondrocytes
were injected directly into the defect and evenly distributed
(Fig. 1). The joint was kept dry and under traction for an-
other 20min to ensure a proper adhesion of the spheroids.
Rehabilitation protocol
Indomethacin was administered for 3 weeks postopera-
tively for heterotopic ossification prophylaxis. Patients
were kept with 15 kg partial weight bearing for 6 weeks
after the ACI. Physiotherapy and continuous passive mo-
tion (CPM) or static cycling was executed from the first
postoperative day. Non-impact sports were allowed after 3
months and impact sports 6 months after the procedure.
Full contact sports were not recommended until 1 year
postoperatively.
Evaluation
Patients were evaluated before the index surgery and 6, 12,
24 and 36 months postoperatively by a clinical consultation
using the following hip specific questionnaires: modified
Harris Hip Score (mHHS), international Hip Outcome
Tool (iHOT33) and a subjective hip assessment
(Subjective Hip Value; SHV) [23, 24]. For the subjective
hip value, comparable with the subjective shoulder value
[25], the patient was asked to give the affected hip a value
between 0% and 100% compared with an unimpaired nor-
mal hip. All data until the last available follow-up data is
provided. The minimal clinically important difference
(MCID) was calculated for the mHHS and the iHOT33
regarding the previously determined MCID standards
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[26]. The percentage of patients meeting the minimal clin-
ically important difference was calculated. For the
Subjective Hip Value, there is no defined MCID yet.
Statistical evaluation
The statistical analysis was performed using the IBM SPSS
Statistics software (IBM Corp. Released 2013. IBM SPSS
Statistics, Version 22.0. Armonk, NY: IBM Corp.).
Differences between preoperative and postoperative scores
were evaluated for significance using the Wilcoxon
Test. The level of significance was set at P< 0.05. The cor-
relation coefficient r was calculated for exploration of influ-
encing demographic and patient specific data, like age and
size of the cartilage defect, on the preoperative and postop-
erative results.
RESULTS
Thirty-two consecutive hips (Table I) with a minimum
follow-up of 36 months who were treated with an ACI for
acetabular cartilage defects. One male patient was treated
with a bilateral ACI procedure. There were 4 female and
28 male cases and the mean age was 33 (range: 18–49)
years. In 13 cases the left and in 19 cases the right hip was
affected. The average defect size measured 4.9 (range: 2–
6) cm2. In 7 cases a cam FAI and in 25 cases a combined
cam and pincer impingement was present.
The average time between the initial procedure with
harvesting of the chondrocytes and the autologous chon-
drocyte implantation was 9 (6–10) weeks. Two patients
were not available after the 1-year-follow-up (one patient
not contactable, one female patient in treatment for breast
cancer, follow-up rate at the 2- and 3-year follow-up 94%).
The arthroscopic ACI application was feasible in all cases.
No surgery related complications were noted. In two cases
(7%) cell cultivation failed due to unknown reason. These
two patients decided to undergo a second harvest procedure
and the repeated cell cultivation was successful. Despite a
third surgery the two patients were satisfied with the surgical
result, reporting 95 and 96 points in the mHHS, 98% and
100% in the iHOT33 and 95% and 100% in the SHV.
Fig. 1. Arthroscopy of the central compartment of a left hip of a 26-year-old male patient. (A) MRI showing a large inverted ‘Oreo’
cookie sign [37]. (B) The diagnostic evaluation shows a large full-thickness acetabular cartilage ﬂap with disruption of the chondrola-
bral transition zone. (C) The defect is debrided using a curette. (D) Contained cartilage defect after debridement of the unstable car-
tilage parts and reﬁxation of the labrum. (E and F) Eight weeks after the initial hip arthroscopy the spheroids are inserted using the
applicator.
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Evaluation of the outcome measurements showed a sig-
nificant increase (P< 0.05) between the preoperative
scores and all follow-up data in the mHHS, iHOT33 and
the SHV (Fig. 2). At the final follow-up of 3 years, the
scores had improved from 64 to 91 points (P< 0.001) in
the mHHS, from 44% to 86% (P< 0.001) in the iHOT33
and from 54% to 87% (P< 0.001) in the SHV. The per-
centage of patients meeting the MCIS was 93% for the
mHHS and 100% for the iHOT33. In the mHHS the
scores consolidated after the 6-month follow-up, showing
higher average scores without statistically significant differ-
ences (P> 0.05). For the iHOT33 the patients improved
statistically significant between all follow-up times except
between 12 and 24 (P¼ 0.21) and 24 and 36 months
(P¼ 0.065). The same improvements could be seen for
the SHV were the differences between the 12 and 24
(P¼ 0.61) and the 24- and 32-month follow (P¼ 0.050)
up showed no statistically significant differences.
The age did not show a relevant influence on the pre-
or postoperative results in the mHHS, iHOT33 or the
SHV. Interestingly, the age at the time of operation had a
significant correlation with the size of the cartilage defect
(r¼ 0.41, P¼ 0.038). Patients with a smaller cartilage de-
fect (<median defect size of 4.75 cm2) were significantly
younger than patients with larger defects in this patient
population (29.6 versus 34.2 years, P¼ 0.044). The size of
the cartilage defect showed no relevant correlation with
the pre- or postoperative results in the mHHS, iHOT33
and the SHV at any time.
Gender specific evaluation showed lower average pre-
operative scores in the four female patients compared with
the male patients. They presented with lower average
scores in the mHHS (50 versus 65 points), iHOT33 (37
versus 45%) and SHV (45 versus 54). In the postoperative
follow-up controls, relevant differences could no longer be
seen in the mHHS (88 versus 92 points) in the iHOT33
(87 versus 86%) and in the SHV (85 versus 88%). The
four female patients were slightly older (37 versus 33
years) and the initial size of the cartilage defect was mar-
ginally larger in female patients (5, 1 versus 4, 8 cm2). Due
to the small sample size of female patients in this cohort,
no statistical analysis of the differences in male and female
patients was performed.
Complications
No surgery related complications were noted. In two cases
(7%) cell cultivation failed due to unknown reason. These
two patients decided to undergo a second harvest procedure
and the repeated cell cultivation was successful. Despite a
third surgery the two patients were satisfied with the surgical
result, reporting 95 and 96 points in the mHHS, 98% and
100% in the iHOT33 and 95% and 100% in the SHV.
DISCUSSION
In this investigation, we could show that that ACI in large
cartilage defects creates good to excellent 3-year results.
The patients continuously improved from preoperative to
the latest postoperative follow-up with 93% of the patients
meeting the MCID in the mHHS and 100% in the
iHOT33. This was seen best in the nuanced and rather
subjective scoring systems like the iHOT33 and the SHV
although the higher average scores among 12, 24 and 36
months showed no statistically significant differences. In
contrast to that, the mHHS rapidly improved in the early
postoperative stage to a maximum. This reveals the limita-
tions and the known sealing effect of this score [26], who
was not designed as a score for hip preservation surgery in
the first place. It is known that the mHHS does not cap-
ture any differences in 25% of the observations at the
upper end of the scales [27, 28] and may therefore over-
estimate the patients’ function after hip arthroscopy and
may not resemble the patients’ satisfaction in the typical
young and active patient population [29]. The results also
show that the biggest improvements are seen within 1 year
after surgery, which tend to show further improvements
after 1 year but without statistical significance.
Cartilage defects resemble the most important prognos-
tic factor in FAI surgery with several investigations report-
ing poorer outcome in patients with large cartilage defects
[2, 30–32]. According to this we detected low average
scores preoperatively in the mHHS (64 points) as well as
in patient reported outcome tools like the iHOT33 (44%)
Table I. Patient demographics
Characteristics Results (range)




Defect size in cm2 4.9 (2–6)















edizinische Bibliothek user on 31 M
ay 2019
and the SHV (54%), reflecting relevant complaints in daily
living of the patients. Despite the large cartilage defects
(average 4.9 cm2) in this series, the patients improved sig-
nificantly after FAI correction and the ACI procedure,
showing excellent mid-term results (mHHS 91 points,
iHOT33 86%, SHV 87%) after 36 months.
Compared with previous reported results we could find
no correlation between the size of the cartilage defect and
the postoperative results in the scores. A medium but not
significant correlation (r¼0, 52) was reported before
between the cartilage defect size and the subjective patient
satisfaction 12 months postoperatively [18]. In this investi-
gation with a larger patient population and a longer follow-
up, this effect could not be confirmed any more.
Interestingly the data showed that the size of the cartil-
age defect correlated significantly with the age of the pa-
tient (r¼ 0.41, P¼ 0.038). Patient with a cartilage defect
size smaller than the median size in this population were
significantly younger. This might be caused by the longer
duration of the FAI and emphasizes early diagnosis and
treatment of symptomatic patients.
Age itself resembled no predicting factor for the pre- or
postoperative results in this patient population. This is sup-
ported by findings that hip arthroscopy is a valuable tool
even in the elderly patient without relevant signs of osteo-
arthritic changes [33].
Only 13% of this population consisted of female
patients. This may be interpreted by the higher incidence
of cam impingement in male patients [34]. Although we
could show poorer preoperative results in those four fe-
male patients compared with the male population, the
results equaled in the postoperative controls.
Though no surgery related complications could be seen,
cell cultivation failed in two patients. This is a relevant
problem as it either means an additional surgery for the pa-
tient for repeated cartilage–bone cylinder harvesting with a
prolonged rehabilitation due to the delayed ACI procedure
or a complete failure of the ACI procedure leaving the
large defect only with a cartilage debridement from the ini-
tial surgery. In the two cases the patients decided to under-
go a second cartilage harvesting with a successful ACI
procedure. The patients were satisfied with their outcome
showing excellent results in the scores.
Treatment options for large acetabular cartilage defects
are still a matter of debate. The injectable autologous chon-
drocyte implantation resembles a new treatment option.
As there is no need for a scaffold material, it offers a tech-
nically less demanding arthroscopic option without the risk
of a dislocation of the scaffold material [15, 35]. Early stud-
ies could show the feasibility of this procedure in the set-
ting of hip arthroscopy [16, 17] and short-term results
have been promising [18, 36].
Fig. 2. Outcome measurement tools at the different follow-up times. *P< 0.05.
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Limitations
One limitation is the relatively small sample size, but still
this study represents the largest published number of
patients treated with an injectable ACI in the hip. The lack
of a randomized control group comparing the ACI with
other cartilage therapies like the microfracture procedure is
a weakness of the study. Generating a numerically suffi-
cient control cohort is difficult in those patients, as most of
the patients choose the potentially more successful ACI in
large cartilage defects.
CONCLUSION
Injectable ACI is a reliable procedure treating full-
thickness acetabular cartilage defects leading to promising
results 3 years postoperatively with a significant increase in
all scores despite large acetabular cartilage defects in the
weight-bearing zone.
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